• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Illumina expects EU order to keep Grail a separate company

September 20, 2021 by David Barret Leave a Comment

September 20, 2021

By Foo Yun Chee

BRUSSELS (Reuters) -Illumina Inc expects an EU order to keep recently acquired Grail Inc as a separate company, the U.S. life sciences company said on Monday, hours after EU antitrust regulators warned of interim measures for closing the deal before their approval.

The company is likely to face other measures on top of the hold separate order, however, with the EU competition enforcer sending a warning to other companies.

Illumina finalised the Grail takeover last month and said it would hold the company separate while waiting for a European Commission decision on the deal, defying EU merger rules against gun-jumping.

Previous instances of gun-jumping have resulted in companies being hit with million-euro fines. Sanctions can be as much as 10% of a company’s global turnover.

“We had anticipated that the Commission would seek to impose a hold separate order, and this is the reason why it has already voluntarily agreed to such an arrangement; their proposals are based on Illumina’s voluntary undertakings,” Illumina said in a statement.

It said it would discuss certain changes suggested by the EU in the coming days.

The EU competition enforcer earlier on Monday said it had sent a statement of objections or charge sheet to the companies, setting out the interim measures it plans to take. It did not provide details.

Under EU merger rules, the competition watchdog can order companies to unwind their deals or sell off shares or assets acquired for violations.

Commission Vice-President Margrethe Vestager underlined the seriousness of Illumina’s actions, saying it was the first time companies had openly implemented a deal while regulators were still investigating.

“The standstill obligation is a cornerstone of our ex-ante merger control regime which aims at preventing harmful effects to competition while our review is ongoing,” she said in a statement.

The Commission said the interim measures aim to restore and maintain effective competition pending a final decision on the deal.

The Commission will make a final decision on the measures after receiving the companies’ response.

(Reporting by Foo Yun Chee in BrusselsEditing by Jan Harvey and Matthew Lewis)

Source Link Illumina expects EU order to keep Grail a separate company

David Barret
David Barret

Related posts:

  1. Lebanon agrees new government to tackle economic collapse
  2. India, Australia eye closer security ties as 9/11 anniversary marked
  3. Motor racing-Mercedes boss says F1 sprint format is ‘not fish, not meat’
  4. In Hungary, pope says anti-Semitism ‘fuse’ must not be allowed to burn

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Musk Outlines The Questionable Reason He Wants To Get To Mars So Badly, NASA Astronaut Responds
  • In 1972 The Soviets Launched A Spacecraft Bound For Venus. In The Next Few Days, It Will Return To Earth
  • Sounds From Inside A Star Reveal Unexpected Properties Of An Aging Orange Dwarf
  • Hear An Elephant Reunion Spark Sounds Even Keepers Had Not Heard Before
  • Why Do Elevators Have Mirrors Inside Them?
  • Cuttlefish Communicate With Arm Waving And Can Sense The Ripples With Their Bodies
  • First Ever Fatal Bear Attack In Florida Leads To The Deaths Of 3 Black Bears
  • Pathogenic Fungal Spores Found Surviving Miles Above Our Heads In Earth’s Stratosphere
  • “Alchemy” In Action As CERN Detects Lead Atoms Turning Into Gold
  • When Did The Earth’s Magnetic Field Form?
  • Who Were The Mysterious “Sea Peoples”, Destroyers Of The Ancient Empires?
  • Galaxy’s Extreme Core Might Have A Whole New Source Of Ghostly Particles
  • 20 Years Of “Very Concerning” Data Concludes Cats Can Catch Bird Flu And Could Pass It To Humans
  • The Ancient Pythagorean “Cup Of Justice” Pranks Users If They Fill It With Too Much Wine
  • When It Comes To Pain, The Nocebo Effect Beats The Placebo Effect
  • English Speakers Obey This Quirky Grammar Rule, Even If They Don’t Know It
  • How Is The Black, White, And Secret Third Smoke Made During The Conclave?
  • Can Children Help Each Other Pass The Famous Marshmallow Test?
  • California’s Highest-Altitude Tree Found By Happy Accident At 12,657 Feet
  • Is The Spiny Devil Katydid The Strangest Insect In The World? You Tell Us
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version